Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
Milda Vysniauskaite, H.-J. Hertfelder, Johannes Oldenburg, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0124912-e0124912
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Mast cell activation syndromes
Cem Akin
Journal of Allergy and Clinical Immunology (2017) Vol. 140, Iss. 2, pp. 349-355
Closed Access | Times Cited: 161
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome
Peter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
International Archives of Allergy and Immunology (2019) Vol. 180, Iss. 1, pp. 44-51
Open Access | Times Cited: 113
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management
Mariana Castells, Joseph H. Butterfield
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 7, Iss. 4, pp. 1097-1106
Closed Access | Times Cited: 109
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
Theoharis C. Theoharides, Irene Tsilioni, Huali L. Ren
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 6, pp. 639-656
Open Access | Times Cited: 101
Mast cell disorders in Ehlers–Danlos syndrome
Suranjith L. Seneviratne, Anne Maitland, Lawrence B. Afrin
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2017) Vol. 175, Iss. 1, pp. 226-236
Open Access | Times Cited: 92
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
Catherine R. Weiler, K. Frank Austen, Cem Akin, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 883-896
Open Access | Times Cited: 86
Diagnosis of mast cell activation syndrome: a global “consensus-2”
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, et al.
Diagnosis (2020) Vol. 8, Iss. 2, pp. 137-152
Open Access | Times Cited: 82
Characterization of Mast Cell Activation Syndrome
Lawrence B. Afrin, Sally Self, Jeremiah Menk, et al.
The American Journal of the Medical Sciences (2016) Vol. 353, Iss. 3, pp. 207-215
Open Access | Times Cited: 83
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 11, pp. 3918-3928
Open Access | Times Cited: 51
Mast Cell Activation Syndrome: A Primer for the Gastroenterologist
Leonard B. Weinstock, Laura Pace, Ali Rezaie, et al.
Digestive Diseases and Sciences (2020) Vol. 66, Iss. 4, pp. 965-982
Closed Access | Times Cited: 47
Using the Right Criteria for MCAS
Theo Gülen
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 39-51
Open Access | Times Cited: 6
Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis
Joseph H. Butterfield, Anupama Ravi, Thanai Pongdee
Immunology and Allergy Clinics of North America (2018) Vol. 38, Iss. 3, pp. 397-410
Closed Access | Times Cited: 41
Quantification of human diamine oxidase
Thomas Boehm, Sophie Pils, Elisabeth Gludovacz, et al.
Clinical Biochemistry (2016) Vol. 50, Iss. 7-8, pp. 444-451
Closed Access | Times Cited: 38
Mast Cells, Mastocytosis, and Related Disorders
Go J. Yoshida
New England Journal of Medicine (2015) Vol. 373, Iss. 19, pp. 1884-1886
Closed Access | Times Cited: 37
Prevalence and risk factors for fragility fracture in systemic mastocytosis
Yannick Degboé, M. Eischen, Delphine Nigon, et al.
Bone (2017) Vol. 105, pp. 219-225
Closed Access | Times Cited: 36
Nonclonal Mast Cell Activation Syndrome
Matthew J. Hamilton
Immunology and Allergy Clinics of North America (2018) Vol. 38, Iss. 3, pp. 469-481
Open Access | Times Cited: 29
Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
Peter Valent, Cem Akin, Michel Arock
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 3, pp. 133-141
Open Access | Times Cited: 3
Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022
Joseph H. Butterfield
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1974-1984
Closed Access | Times Cited: 14
Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
H. Seidel, H.-J. Hertfelder, Johannes Oldenburg, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8960-8960
Open Access | Times Cited: 13
Chromogranin A is not a biomarker of mastocytosis
Pahul Hanjra, Chyi‐Chia Richard Lee, Irina Marić, et al.
The Journal of Allergy and Clinical Immunology In Practice (2017) Vol. 6, Iss. 2, pp. 687-689.e4
Open Access | Times Cited: 8
Case Report: Treatment of systemic mastocytosis with sunitinib
Gerhard J. Molderings, Lawrence B. Afrin, H.-J. Hertfelder, et al.
F1000Research (2017) Vol. 6, pp. 2182-2182
Open Access | Times Cited: 5
The roles of mast cells in allergic inflammation and mast cell-related disorders
Hee-Kyoo Kim
Allergy Asthma & Respiratory Disease (2017) Vol. 5, Iss. 5, pp. 248-248
Closed Access | Times Cited: 4
White matter abnormalities are also repeatedly present in patients with systemic mast cell activation syndrome
Britta Haenisch, GJ Molderings
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock
E. Casassa, C. Mailhol, É. Tournier, et al.
Allergology International (2018) Vol. 68, Iss. 1, pp. 119-121
Open Access | Times Cited: 4
Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung
Bernd Sido, Jürgen Homann, H.-J. Hertfelder, et al.
Der Chirurg (2019) Vol. 90, Iss. 7, pp. 548-556
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top